The decrease in short interest for Viking Therapeutics suggests that investors are becoming more optimistic about the company's future performance. This is further highlighted by the comparison with its peers, where VKTX has a significantly higher short interest percentage, yet it's decreasing. This could indicate a potential short squeeze or a general market consensus that the stock is undervalued, leading to a positive short-term impact on the stock price.